Patrick J Kiel, Kellie L Jones. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Antimetabolites, Antineoplastic/administration & dosageAntimetabolites, Antineoplastic/adverse effectsAntimetabolites, Antineoplastic/therapeutic useCombined Modality Therapy/adverse effectsEyelidsFaceHumansLymphoma, Large B-Cell, Diffuse/drug therapyLymphoma, Large B-Cell, Diffuse/radiotherapyMaleMethotrexate/administration & dosageMethotrexate/adverse effectsMethotrexate/therapeutic useMiddle AgedRadiodermatitis/chemically inducedRadiodermatitis/drug therapyRetinal Neoplasms/drug therapyRetinal Neoplasms/radiotherapyTreatment Outcome
Substances： See more » Antimetabolites, AntineoplasticMethotrexate
Year: 2011 PMID： 21205951 DOI： 10.1345/aph.1P404
Source DB: PubMed Journal: Ann Pharmacother ISSN： 1060-0280 Impact factor: 3.154